Screening for fragile X syndrome among neurobehavioural patients from Kolkata, Eastern India

Journal of Clinical and Diagnostic Research

Volumn 3, Issue 1, 2009, Pages 1266-1273

  Bhowmik, D A ^a   Dutta, S ^a   Chatterjee, A ^a   Sinha, S ^a   Chattopadhyay, A ^a   Mukhopadhyay, Kanchan ^a  

^a Manovikas Biomedical Research and Diagnostic Centre   (India)

Author keywords

CGG repeat; FMRP; Fragile X syndrome; MR; MS PCR

Indexed keywords

CYTOSINE; FRAGILE X MENTAL RETARDATION PROTEIN; GUANINE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; CHILD; CHROMOSOME ANALYSIS; DNA METHYLATION; DOWN SYNDROME; EPILEPSY; FEMALE; FRAGILE X SYNDROME; GENE AMPLIFICATION; GENE FUNCTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INDIA; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MOLECULAR BIOLOGY; MOSAICISM; NUCLEOTIDE REPEAT; OUTPATIENT; POLYMERASE CHAIN REACTION; PREVALENCE; PROMOTER REGION; SCREENING;

EID: 61349121552     PISSN: None     EISSN: 0973709X     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Crawford DC, Acuna JM, Sherman SL. FMR1 and the fragile X syndrome: Human genome epidemiology review. Genet Med 2001; 3:359-71.
2. Turner G, Webb T, Wake S, Robinson H. Prevalence of fragile X syndrome. Am J Med Genet 1996; 64: 196-97.
3. Warren ST, Nelson DI. Advances in molecular analysis of fragile X syndrome. J Am Med Assoc 1994; 271:536-42.
4. Jain U, Verma IC, Kapoor AK. Prevalence of fragile X (A) syndrome in mentally retarded children at a genetics referral centre in Delhi, India. Indian J Med Res, 1998; 108:12-16.
5. Baskaran S, Naseerullah MK, Manjunatha KR, et al. Triplet repeat polymorphism & fragile X syndrome in the Indian context. Indian J Med Res. 1998; 107:29-36.
6. Sharma D, Gupta M, Thelma BK. Expansion mutation frequency and CGG/GCC repeat polymorphism in FMR1 and FMR2 genes in an Indian population. Genet Epidemiol. 2001; 20:129-44.
7. Saha S, Karmakar P, Chatterjee C, et al. Fragile X syndrome in Calcutta, India. Ann Clin Biochem. 2001; 38:264-71.
8. Bennetto L, Pennington BF. The neuropsychology of fragile X syndrome. In: Hagerman RJ, Cronister A, editors. Fragile X syndrome: diagnosis, treatment and research. Baltimore: The Johns Hopkins University Press; 1996. p. 210-48.
9. Turner G, Daniel A, Frost M. X-linked mental retardation, macro-orchidism, and the Xq27 fragile site. J Pediatr. 1980; 96:837-41.
10. Hagerman RJ, Synhorst DP. Mitral valve prolapse and aortic dilatation in the fragile X syndrome. Am J Med Genet. 1984; 17:123-31.
11. Hagerman RJ, Altshul-Stark D, McBogg P. Recurrent otitis media in the Fragile X syndrome. Am J Dis Child. 1987; 141:184-87.
12. Sabaratnam M, Vroegop PG, Gangadharan SK. Epilepsy and EEG findings in 18 males with fragile X syndrome. Seizure,. 2001; 10:60-63.
13. Bailey DB, Mesibov G, Hatton DD, et al. Autistic behavior in young boys with fragile X syndrome. J Autism Dev Disord. 1998; 28:499-508.
14. Baumgardner TL, Reiss AL, Freund LS, Abrams MT. Specification of the neurobehavioral phenotype in males with fragile X syndrome. Pediatrics. 1995; 95:744-52.
15. Borghgraef M, Fryns JP, Dielkens A, et al. Fragile (X) syndrome: a study of the psychological profile in 23 prepubertal patients. Clin Genet . 1987; 32:179-86.
16. Bregman JD, Leckman JF, Ort SI. Fragile X syndrome: genetic predisposition to psychopathology. J Autism Dev Disord. 1988; 18: 343-54.
17. Berry-Kravis E. Epilepsy in fragile x syndrome. Dev Med and Child Neurol. 2002; 44:724-28.
18. Hanson JE, Blank M, Valenzuela RA, et al. The functional nature of synaptic circuitry is altered in area CA3 of the hippocampus in a mouse model of Down's syndrome. J Physiol. 2007a; 579: 53-67.
19. Hanson JE, Madison DV. Presynaptic Fmr1 Genotype Influences the Degree of Synaptic Connectivity in a Mosaic Mouse Model of Fragile X Syndrome. J Neurosci 2007b; 27:4014-18.
20. Ashley CT Jr, Wilkinson KD, Reines D, Warren ST. FMR1 protein: conserved RNP family domains and selective RNA binding. Science 1993; 262:563-66.
21. Eichler EE, Richards S, Gibbs RA, Nelson DL. Fine structure of the human FMR1 gene. Hum Mol Genet, 1993; 2:1147-1153. Erratum in: Hum Mol Genet 1994; 3:684-85.
22. Devys D, Lutz Y, Rouyer N, et al. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 1993; 4:335-40.
23. Feng Y, Absher D, Eberhart DE, et al. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol.Cell. 1997; 1:109-18.
24. Jin P, Warren TS. New insights into fragile X syndrome: from molecules to neurobehaviors, Trends in Biochemical Sciences 2003; 28: 152-58.
25. Oberle I, Rousseau F, Heitz D, et al. Instability of a 550 bas-pair DAN segment and abnormal methylation in fragile x syndrome. Science 1991; 252:1097-1102.
26. Verkerk AJ, Pieretti M, Sutcliffe JS, et al. Identification of a gene (FMR-1) containing CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile x syndrome. Cell 1991; 65:905-14.
27. Hammond LS, Macias MM, Tarleton JC, et al. Fragile X syndrome and deletions in FMR1: new case and review of the literature. Am J Med Genet 1997; 72:430-34.
28. Nolin SL, Brown WT, Glicksman A et al. Expansion of the Fragile X CGG repeat in females with premutation and intermediate alleles. Am. J. Hum. Genet 2003; 72:454-64.
29. Weinhausel A, Haas OA. Evaluation of the fragile X (FRAXA) syndrome with methylation-sensitive PCR. Hum Genet 2001; 108:450-58.
30. Brown WT, Houck GE Jr, Jeziorowska A, et al. Rapid fragile X carrier screening and prenatal diagnosis using a non-radioactive PCR test. J Am Med Assoc 1993; 270: 1569-75.
31. Willemsen R, Mohkamsing S, de Vries B, et al. Rapid antibody test for fragile X syndrome. Lancet 1995; 345:1147-48.
32. Willemsen R, Smits A, Mohkamsing S, et al. Rapid antibody test for diagnosing fragile X syndrome: a validation of the technique. Hum Genet 1997; 99:308-11.
33. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders, 4th ed. (DSM-IV). Washington DC (USA), 1994.
34. Kähkönen M. Population cytogenetics of folate-sensitive fragile sites. Hum Genet 1988; 80:344-48.
35. Hungerford DA. Leukocytes cultured from small inocula of whole blood and the preparation of metaphase chromosomes by treatment with hypotonic KCl. Stain Technol 1965; 40:333-38.
36. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988; 16:1215.
37. Martin JP, Bell J. A pedigree of mental defect showing sex-linkage. J Neurol Psychiatry 1943; 6:154-57.
38. Magenis RE, Hecht F, Lovrien EW. Heritable Fragile Site on Chromosome 16: Probable Localization of Haptoglobin Locus in Man. Science 1970; 170: 85-87.
39. Sutherland GR. Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium. Science 1977; 197: 265-66.
40. Maino DM, Maino JH, Maino SA. Mental retardation syndromes with associated ocular defects. J Am Optom Assoc 1990; 61:707-16.
41. Brown WT. Perspectives and molecular diagnosis of Fragile X syndrome. Clin Lab Med 1995; 15: 859-75.
42. Elango R, Verma IC. Fragile X syndrome among children with mental retardation. Indian J Pediatr 1996; 63:533-38.
43. Rousseau F, Rouillard P, Morel ML, et al. Prevalence of carriers of permutation-size alleles of the FMR1 gene and implications for the population genetics of Fragile X syndrome. Am J Hum Genet 1995; 57:1006-18.
44. Arinami T, Asano M, Kobayashi K, et al. The data on the CGG repeat at the fragile X site in the non-retarded Japanese population and family suggest the presence of a subgroup of normal alleles predisposing to mutation. Hum Genet 1993; 92:431-36.
45. Fu YH, Kuhl DPA, Pizzuti A, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991; 67:1047-58.
46. Chen TA, Lu XF, Che PK, Ho Walter KK. Variation of the CGG repeat in the FMR-1 gene in normal and fragile X Chinese subjects. Ann Clin Biochem 1997; 34:517-20.